# Amgen Inc. (AMGN) — Q3-2023 Earnings Results

**Report date:** 2023-10-31 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2023

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 2.85%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $4.96 | N/A | +6.55% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding future growth. They emphasized the importance of their product pipeline despite market challenges.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They noted ongoing challenges in the market but expressed confidence in their pipeline.

> The focus remains on innovation and maintaining market leadership.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Amgen's earnings report showed a positive surprise in EPS, which indicates better-than-expected profitability. However, the stock fell by 2.85% likely due to the lack of revenue details and guidance. Investors may be concerned about future performance without clear direction from management.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2023_